Will Medtech M&A Pick Back up in the Second Half?

Will medtech M&A pick back up in the second half?

The year kicked off with a handful of acquisitions from top companies. Dealmaking has since slowed amid economic uncertainty but could be poised for a rebound.

Regional M&A outlook: steady deals despite uncertainty

Regional M&A activity fell in 2024, near 2020 pandemic levels Interest rate relief sparked a Q4 2024 uptick in deals Uncertainty over tariffs slows activity in lumber and steel sectors Baby boomer retirements and $3.5T in dry powder drive buyer demand Bryan A. Redding doesn’t like to predict future activity when it comes to mergers and acquisitions (M&A). “It’s always hard to use your crystal ball and see anything with certainty, especia…